NCT06361238View on ClinicalTrials.gov

Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery

PHASE3RecruitingINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

November 19, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2028

Conditions
Delirium, Postoperative
Interventions
DRUG

Liraglutide injection

Subcutaneous injection of liraglutide: 0.6 mg administered the day before surgery, 1.8 mg administered post-anesthesia induction on the day of surgery, followed by 0.6 mg daily for the first three postoperative days.

DRUG

Placebo injection

Subcutaneous injection of Placebo: the same volume as liraglutide administrated at the corresponding times.

Trial Locations (1)

210000

RECRUITING

Wenxue liu, Nanjing

All Listed Sponsors
lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER